Moreover, AF127577.4-ORF led to a decrease in phosphorylated ERK (p-ERK) level in GBM cells (Fig. 6E), which suggested the inhibitory function of the micropeptide in the activation of the ERK pathway. Here, MAPK1 is linked to glioblastoma.